Tevogen Bio Holdings Inc.

Market Cap

$34M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$10.47-$7.73 (-42.47%)

Jun 5, 2026

52W High $71.5052W Low $4.29

Company Details

Tevogen Bio Holdings Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has...

CEO

—

IPO Date

Feb 15, 2024

Website

tevogen.com

Key Metrics TTM

Revenue

-100.0% YoY

Net Income

-$21M

EPS (Diluted)

Free Cash Flow

-$12M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q4 2026

Aug 13, 2026

PENDING

Q3 2026

May 15, 2026

$0-100.0%

Q2 2026

Mar 31, 2026

Q1 2026

Nov 14, 2025

FY 2025

Aug 14, 2025

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee